Meeting
2014 ASCO Annual Meeting
CK14, FOXA1, and androgen receptor (AR) expression in patients (pts) with triple-negative breast cancer (TNBC).
Authors
Ayca Gucalp
Memorial Sloan Kettering Cancer Center, New York, NY
Ayca Gucalp , Margaret D. Krasne , Kiran A. Jakate , Esther N. Drill , Yong Hannah Wen , Muzaffar Akram , Alice Y. Ho , Gaorav P. Gupta , Edi Brogi , Clifford A. Hudis , Tiffany A. Traina
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy
Track
Breast Cancer
Sub Track
Triple-Negative Breast Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 1126)
DOI
10.1200/jco.2014.32.15_suppl.1126
Abstract #
1126
Poster Bd #
219
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Androgen receptor (AR) expression in primary breast cancer (BC): Correlations with clinical characteristics and outcomes.
First Author: Neelima Vidula
Poster
2016 ASCO Annual Meeting
Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes.
First Author: Angela Santonja
Poster
2015 Breast Cancer Symposium
Caveolin-1: Oncogenic role in breast cancer? Clues from molecular profiling.
First Author: Rebecca Feldman
Poster
2014 ASCO Annual Meeting
Expressions of EGFR, HER2, and HER3 and their correlations with clinical characteristics in oropharyngeal squamous cell carcinoma (OPSCC).
First Author: Nabil F. Saba